Ethanol sclerotherapy twice and one laparoscopic surgery for stage IV pelvic endometriosis and bilateral ovarian endometrioma over two decades: a case report

In: International Journal of Reproduction, Contraception, Obstetrics and Gynecology · 2026 · doi:10.18203/2320-1770.ijrcog20261465 · W7160496360
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-08

This case report describes a patient with stage IV endometriosis who avoided repeat major surgery through two ethanol sclerotherapy treatments for recurrent ovarian endometriomas, successfully conceiving and delivering two children.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text

This single-patient case report describes a woman with stage IV pelvic endometriosis and bilateral ovarian endometriomas followed over more than two decades, who initially underwent laparotomy and later operative laparoscopy with adhesiolysis and endometriotic lesion ablation plus bilateral endometrioma management, with methylene blue chromotubation showing bilateral tubal patency. After ovarian cyst formation following ovulogens and subsequent recurrence of a large right endometrioma, the patient received ultrasound-guided ethanol sclerotherapy (EST) twice for recurrent ovarian “chocolate” cysts, with 120 mL aspirated before left-sided EST and 7 mL absolute alcohol injected. Spontaneous conception occurred in 2018, resulting in a live birth, and EST was used again in 2020, allowing avoidance of repeat major surgery per the report’s account. The paper’s limitation is that it provides only descriptive outcomes in one case, without a comparator or generalizable efficacy assessment. This paper is centrally about endometriosis — it reports longitudinal management of stage IV pelvic endometriosis and bilateral ovarian endometriomas using ethanol sclerotherapy.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

In January 2008, Mrs. BP, at the age of 28 years, a para one, live child one, previous lower segment caesarean section (LSCS), and an ovarian cyst, left endometrioma, underwent laparotomy and ovarian cystectomy under spinal anaesthesia. On 12 July 2008, a scan revealed well defined cystic lesions in the right adnexa, 5.0×4.8 cm, and 2.3×2.1 cm and left ovary two cysts measuring 1.8×1.2, and 2.6×1.6 cm. In December 2008, operative laparoscopy was performed. Adhesiolysis, fulguration with dessication of all the visible endometriotic lesions, right ovarian chocolate cystectomy, 10×8 cm. was done. Left ovary had a 1.5 cm endometriotic cyst, that was drained and cyst wall cauterized. Pouch of Douglas, the bowel was pulled up. Methylene blue chromotubation for the patency of the fallopian tubes was positive on both the sides. Diagnosis, stage IV endometriosis. She was treated with ovulogens for two or three cycles. This resulted in ovarian cyst formation, hence stopped. On 17 April 2010, ultrasonography (USG) evidence of a large recurrent right ovarian endometrioma of 10×9 cm one and a half years after the laparoscopic management of stage IV endometriosis in 2008. The first ethanol sclerotherapy (EST) was done in this case on 27 November 2010, under USG guidance. She conceived spontaneously in 2018. Second delivery by LSCS in USA, a boy 4.125 kg on 05 December 2018. Left ovarian chocolate cyst noted in February 2020, EST was done a second time. Aspirated 120 ml of chocolate thick material. On 24 February 2020, injected 7 ml of absolute alcohol into the left ovarian chocolate cyst under ultrasound guidance. She had a second child, she could avoid a repeat major surgery, both the objectives could be achieved and were facilitated by EST done on two occasions. EST serves to ameliorate endometriosis and serves as an additional modality of treatment in select cases.
Full text 10,298 characters · extracted from oa-doi-fallback · click to expand
Ethanol sclerotherapy twice and one laparoscopic surgery for stage IV pelvic endometriosis and bilateral ovarian endometrioma over two decades: a case report DOI: https://doi.org/10.18203/2320-1770.ijrcog20261465Keywords: Endometriosis, Endometrioma, Ethanol sclerotherapy, Endometriotic cystectomy, Secondary infertilityAbstract In January 2008, Mrs. BP, at the age of 28 years, a para one, live child one, previous lower segment caesarean section (LSCS), and an ovarian cyst, left endometrioma, underwent laparotomy and ovarian cystectomy under spinal anaesthesia. On 12 July 2008, a scan revealed well defined cystic lesions in the right adnexa, 5.0×4.8 cm, and 2.3×2.1 cm and left ovary two cysts measuring 1.8×1.2, and 2.6×1.6 cm. In December 2008, operative laparoscopy was performed. Adhesiolysis, fulguration with dessication of all the visible endometriotic lesions, right ovarian chocolate cystectomy, 10×8 cm. was done. Left ovary had a 1.5 cm endometriotic cyst, that was drained and cyst wall cauterized. Pouch of Douglas, the bowel was pulled up. Methylene blue chromotubation for the patency of the fallopian tubes was positive on both the sides. Diagnosis, stage IV endometriosis. She was treated with ovulogens for two or three cycles. This resulted in ovarian cyst formation, hence stopped. On 17 April 2010, ultrasonography (USG) evidence of a large recurrent right ovarian endometrioma of 10×9 cm one and a half years after the laparoscopic management of stage IV endometriosis in 2008. The first ethanol sclerotherapy (EST) was done in this case on 27 November 2010, under USG guidance. She conceived spontaneously in 2018. Second delivery by LSCS in USA, a boy 4.125 kg on 05 December 2018. Left ovarian chocolate cyst noted in February 2020, EST was done a second time. Aspirated 120 ml of chocolate thick material. On 24 February 2020, injected 7 ml of absolute alcohol into the left ovarian chocolate cyst under ultrasound guidance. She had a second child, she could avoid a repeat major surgery, both the objectives could be achieved and were facilitated by EST done on two occasions. EST serves to ameliorate endometriosis and serves as an additional modality of treatment in select cases. Metrics References Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet. 2010;27:441-7. DOI: https://doi.org/10.1007/s10815-010-9436-1 Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin N Am. 1997;24:235-58. DOI: https://doi.org/10.1016/S0889-8545(05)70302-8 Exacoustos C, De Felice G, Pizzo A, Morosetti G, Lazzeri L, Centini G, et al. Isolated Ovarian Endometrioma: A History Between Myth and Reality. J Minim Invasive Gynecol. 2018;25(5):884-91. DOI: https://doi.org/10.1016/j.jmig.2017.12.026 Parasar P, Ozcan P, Terry KL. Endometriosis: epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep. 2017;6:34-41. DOI: https://doi.org/10.1007/s13669-017-0187-1 Baraki D, Richards EG, Falcone T. Treatment of endometriomas: surgical approaches and the impact on ovarian reserve, recurrence, and spontaneous pregnancy. Best Pract Res Clin Obstet Gynaecol. 2024;92:102449. DOI: https://doi.org/10.1016/j.bpobgyn.2023.102449 Sanchez AM, Viganò P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20:217-30. DOI: https://doi.org/10.1093/humupd/dmt053 Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108:117-24.e5. Ronsini C, Iavarone I, Braca E, Vastarella MG, De Franciscis P, Torella M. The efficiency of sclerotherapy for the management of endometrioma: a systematic review and meta-analysis of clinical and fertility outcomes. Medicina (Kaunas). 2023;59:1643. Younis JS, Shapso N, Fleming R, Ben-Shlomo I, Izhaki I. Impact of unilateral versus bilateral ovarian endometriotic cystectomy on ovarian reserve: a systematic review and meta-analysis. Hum Reprod Update. 2019;25:375-91. DOI: https://doi.org/10.1093/humupd/dmy049 Castellarnau Visus M, Ponce Sebastia J, Carreras Collado R, Cayuela Font E, Garcia Tejedor A. Preliminary results: ethanol sclerotherapy after ultrasound-guided fine needle aspiration without anesthesia in the management of simple ovarian cysts. J Minim Invasive Gynecol. 2015;22:475-82. DOI: https://doi.org/10.1016/j.jmig.2014.12.158 Ruiz-Flores FJ, Garcia-Velasco JA. Is there a benefit for surgery in endometrioma-associated infertility? Curr Opin Obstet Gynecol. 2012;24:136-40. DOI: https://doi.org/10.1097/GCO.0b013e32835175d9 Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400-12. DOI: https://doi.org/10.1093/humrep/det457 Okagaki R, Osuga Y, Momoeda M, Tsutsumi O, Taketani Y. Laparoscopic findings after ultrasound-guided transvaginal ethanol sclerotherapy for ovarian endometrial cyst. Hum Reprod. 1999;14:270. DOI: https://doi.org/10.1093/humrep/14.1.270 Radosa MP, Meyberg-Solomayer G, Radosa J, Vorwergk J, Oettler K, Mothes A, et al. Standardised registration of surgical complications in laparoscopic-gynaecological therapeutic procedures using the Clavien-Dindo classification. Geburtshilfe Frauenheilkd. 2014;74:752-8. DOI: https://doi.org/10.1055/s-0034-1382925 Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108:117-24.e5. DOI: https://doi.org/10.1016/j.fertnstert.2017.05.015 Ronsini C, Iavarone I, Braca E, Vastarella MG, De Franciscis P, Torella M. The efficiency of sclerotherapy for the management of endometrioma: a systematic review and meta-analysis of clinical and fertility outcomes. Medicina (Kaunas). 2023;59:1643. DOI: https://doi.org/10.3390/medicina59091643 Younis JS, Shapso N, Izhaki I, Taylor HS. Ethanol sclerotherapy for management of endometriomas: an overview of systematic reviews. Front Endocrinol (Lausanne). 2025;16:1612899. DOI: https://doi.org/10.3389/fendo.2025.1612899 Agostini A, De Lapparent T, Collette E, Capelle M, Cravello L, Blanc B. In situ methotrexate injection for treatment of recurrent endometriotic cysts. Eur J Obstet Gynecol Reprod Biol. 2007;130:129-31. DOI: https://doi.org/10.1016/j.ejogrb.2006.01.015 Gonçalves FC, Andres MP, Passman LJ, Gonçalves MO, Podgaec S. A systematic review of ultrasonography-guided transvaginal aspiration of recurrent ovarian endometrioma. Int J Gynaecol Obstet. 2016;134:3-7. DOI: https://doi.org/10.1016/j.ijgo.2015.10.021 Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Intervent Radiol. 2010;27:391-9. DOI: https://doi.org/10.1055/s-0030-1267848 Akamatsu N, Hirai T, Masaoka H, Sekiba K, Fujita T. Ultrasonically guided puncture of endometrial cysts—aspiration of contents and infusion of ethanol. Nihon Sanka Fujinka Gakkai Zasshi. 1988;40:187-91. Chang CC, Lee HF, Tsai HD, Lo HY. Sclerotherapy—an adjuvant therapy to endometriosis. Int J Gynaecol Obstet. 1997;59:31-4. DOI: https://doi.org/10.1016/S0020-7292(97)00122-7 Alborzi S, Askary E, Keramati P, Moradi Alamdarloo S, Poordast T, Ashraf MA, et al. Assisted reproductive technique outcomes in patients with endometrioma undergoing sclerotherapy vs laparoscopic cystectomy: prospective cross-sectional study. Reprod Med Biol. 2021;20(3):313-20. DOI: https://doi.org/10.1002/rmb2.12386 Koo JH, Lee I, Han K, Seo SK, Kim MD, Lee JK, et al. Comparison of the therapeutic efficacy and ovarian reserve between catheter-directed sclerotherapy and surgical excision for ovarian endometrioma. Eur Radiol. 2021;31:543-8. DOI: https://doi.org/10.1007/s00330-020-07111-1 Garcia-Tejedor A, Martinez-Garcia JM, Candas B, Suarez E, Mañalich L, Gomez M, et al. Ethanol sclerotherapy versus laparoscopic surgery for endometrioma treatment: a prospective, multicenter, cohort pilot study. J Minim Invasive Gynecol. 2020;27(5):1133-40. DOI: https://doi.org/10.1016/j.jmig.2019.08.036 Ghasemi Tehrani H, Tavakoli R, Hashemi M, Haghighat S. Ethanol sclerotherapy versus laparoscopic surgery in management of ovarian endometrioma: a randomized clinical trial. Arch Acad Emerg Med. 2022;10:e55. Vaduva CC, Dira L, Carp-Veliscu A, Goganau AM, Ofiteru AM, Siminel MA. Ovarian reserve after treatment of ovarian endometriomas by ethanolic sclerotherapy compared to surgical treatment. Eur Rev Med Pharmacol Sci. 2023;27:5575-82. Lee JK, Ahn SH, Kim HI, Lee YJ, Kim S, Han K, et al. Therapeutic efficacy of catheter-directed ethanol sclerotherapy and its impact on ovarian reserve in patients with ovarian endometrioma at risk of decreased ovarian reserve: a preliminary study. J Minim Invasive Gynecol. 2022;29(2):317-23. DOI: https://doi.org/10.1016/j.jmig.2021.08.018 Miquel L, Preaubert L, Gnisci A, Resseguier N, Pivano A, Perrin J, et al. Endometrioma ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis. PLoS One. 2020;15:e0239846. DOI: https://doi.org/10.1371/journal.pone.0239846 Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:3146-54. DOI: https://doi.org/10.1210/jc.2012-1558 Kim GH, Kim PH, Shin JH, Nam IC, Chu HH, Ko HK. Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis. Eur Radiol. 2022;32:1726-37. DOI: https://doi.org/10.1007/s00330-021-08270-5 Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 2017;96:659-67. DOI: https://doi.org/10.1111/aogs.13082 Lentzaris D, Gkrozou F, Skentou C, Koutalia N, Bais V, Vatopoulou A, et al. Future of sclerotherapy in the treatment of endometriosis: a narrative literature review. Cureus. 2025;17(3):e81215. Sükür YE, Aslan B, Varlı B, Özcan P, Daniilidis A, Kalaitzopoulos DR. Ethanol sclerotherapy for endometriomas in infertile women: a narrative review. J Clin Med. 2024;13:7548. DOI: https://doi.org/10.3390/jcm13247548

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometrioma

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK